VeriMompeg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) é seguro durante a gravidez?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
Related ingredients
Frequently asked questions
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) é seguro durante a gravidez?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment for this specific PEG-6 sesqui(benzotriazolyl t‑butyl hydroxyphenylpropionate) was identified in available regulatory sources. There are no published reproductive or developmental toxicity data specific to this ingredient in PubMed; by default and given its PEGylated UV‑absorber structure the concern is low but dermal exposure is expected to be low but measurable (CosIng / ECHA registration information typically indicate topical use/low dermal absorption for large PEG‑conjugates). Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) é seguro durante a amamentação?
- No data identified showing reproductive or lactation toxicity or transfer in breast milk for this ingredient. Mechanistic or animal evidence of transfer into milk was not found; expected systemic exposure from topical cosmetic use is low but measurable, so marginal potential for maternal systemic exposure exists. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed.
- peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) é seguro para a pele do bebê?
- No infant‑specific toxicity or developmental data were identified. Because the ingredient is a PEGylated benzotriazole UV‑absorber (moderate molecular size) and topical absorption in infants is typically higher than in adults, exposure score is increased by +1 for baby skin; however no evidence was found indicating intrinsic reproductive/developmental hazard. Sources consulted: ECHA (registrations/C&L), PubChem, CosIng, PubMed, EWG.
- Como o VeriMom pontua peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate)?
- O VeriMom pontua peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) na gravidez?
- Veja nossa lista curada de alternativas seguras a peg-6 sesqui(benzotriazolyl t-butyl hydroxyphenylpropionate) com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.